Boditech Med

China-based Autobio Diagnostics Co., Ltd (SHA: 603658) has announced a strategic partnership with South Korea-headquartered Boditech Med Inc. The collaboration, which focuses on the immunoassay field, aims to leverage the respective advantages of both companies in the in vitro diagnostics (IVD) sector to develop the Korean market. No financial details…